SLF2 and SMC5 dysfunction drives HSC aging and predisposes to MDS, defining a new inherited bone marrow failure syndrome
Researchers identified a new inherited bone marrow disorder caused by faulty DNA-repair genes, opening pathways to understand why some people develop blood cancers earlier in life.
Using patient-derived iPSCs harboring compound heterozygous SLF2 mutations, this study demonstrates that the SLF2–SMC5 axis is essential for HSC genome integrity; its disruption induces a senescence-like state with myeloid-biased chromatin remodeling (ATAC-seq) and markedly impaired engraftment, culminating in MDS at young age. The work identifies Atelis Syndrome as a previously unrecognized inherited bone marrow failure syndrome and illuminates how germline DNA-damage response defects can accelerate HSC aging and clonal evolution toward MDS.
What the study was
- Study design
- mechanistic
- Population
- Patients with SLF2 mutations (Atelis Syndrome); patient-derived iPSCs and xenotransplantation models
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Leukemia
Why it surfaced
Disease-defining paper in Leukemia with multi-modal mechanistic evidence (iPSC, xenotransplantation, ATAC-seq); establishes a new IBMFS category relevant to inherited MDS risk and HSC aging biology; dual relevance to hematologic_malignancies (MDS) and rare_diseases (rare IBMFS with unmet need); Kyoto University iPS Cell group using cutting-edge iPSC-disease modeling.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.